Several chemokine ligands are expressed by the tumor: CCL17 and CCL22 promote recruitment of CCR4+ Tregs, while CXCR3—along with its ligands, CXCL9 and CXCL10—drives cytotoxic lymphocyte trafficking into the GBM tumor site. This evidence concerns the gene CXCL9 and neoplasm.